Literature DB >> 20001643

Living with rheumatoid arthritis and experiencing everyday life with TNF-α blockers.

Charlotte Lindén1, Anita Björklund.   

Abstract

The aim of this study was to describe how persons with RA from an area in western Sweden experience everyday life with TNF-α blockers. A purposive sampling of 11 women and four men, with an age ranging from 25 to 70 years, was conducted. A phenomenological approach was used in the study. The data were collected by unstructured in-depth interviews. The data analysis resulted in six code groups, of which four have appurtenant sub-groups. The six code groups are: "A noticeable change dominates the picture"; "Change in bodily and mental symptoms enables activity"; "Enabling care for oneself and others"; "Enabling improved or continued productivity"; "More rewarding leisure time"; and "Drawbacks of the medication". The findings show that most of the informants had experienced dramatic changes in their daily lives since the medication reduced their symptoms, resulting in an increased level of activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20001643     DOI: 10.3109/11038120903480055

Source DB:  PubMed          Journal:  Scand J Occup Ther        ISSN: 1103-8128            Impact factor:   2.611


  5 in total

1.  Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion.

Authors:  Kathleen M Andersen; Ayano Kelly; Anne Lyddiatt; Clifton O Bingham; Vivian P Bykerk; Adena Batterman; Joan Westreich; Michelle K Jones; Marita Cross; Peter M Brooks; Lyn March; Beverley Shea; Peter Tugwell; Lee S Simon; Robin Christensen; Susan J Bartlett
Journal:  J Rheumatol       Date:  2019-02-15       Impact factor: 4.666

2.  Pain and difficulties performing valued life activities in women and men with rheumatoid arthritis.

Authors:  Inger Ahlstrand; Mathilda Björk; Ingrid Thyberg; Torbjörn Falkmer
Journal:  Clin Rheumatol       Date:  2015-01-25       Impact factor: 2.980

3.  Effectiveness and Costs of TNF-Alpha Blocker Use for Patients with Rheumatoid Arthritis.

Authors:  Kavita Nair; Vahram Ghushchyan; Ahmad Naim
Journal:  Am Health Drug Benefits       Date:  2013-03

4.  Emotions related to participation restrictions as experienced by patients with early rheumatoid arthritis: a qualitative interview study (the Swedish TIRA project).

Authors:  Gunnel Östlund; Mathilda Björk; Ingrid Thyberg; Mikael Thyberg; Eva Valtersson; Birgitta Stenström; Annette Sverker
Journal:  Clin Rheumatol       Date:  2014-05-17       Impact factor: 2.980

5.  Experiences of mobility for people living with rheumatoid arthritis who are receiving biologic drug therapy: implications for podiatry services.

Authors:  Lucy Sanders; Margaret Donovan-Hall; Alan Borthwick; Catherine J Bowen
Journal:  J Foot Ankle Res       Date:  2017-03-16       Impact factor: 2.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.